Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Hamblin

Showing results (251-260 of 264) with videos related to

Pageof 27
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)|June 15, 1991
Nucleotide sequence analysis of the V regions of two IgM cold agglutinins. Evidence that the VH4-21 gene segment is responsible for the major cross-reactive idiotypeV Pascual, K Victor, D Lelsz, et al.
American Journal of Respiratory Cell and Molecular Biology|August 1, 1993
Cyclic mechanical deformation stimulates human lung fibroblast proliferation and autocrine growth factor activityJ E Bishop, J J Mitchell, P M Absher, et al.
Scientific Reports|February 1, 2019
The nuclear variant of bone morphogenetic protein 2 (nBMP2) is expressed in macrophages and alters calcium responseClaudia M Tellez Freitas, Haley R Burrell, Jonard C Valdoz, et al.
British Journal of Haematology|October 18, 2005
Differential expression of CD 180 and IgM by B-cell chronic lymphocytic leukaemia cells using mutated and unmutated immunoglobulin VH genesN Porakishvili, N Kulikova, A P Jewell, et al.
Blood|August 1, 2002
Multivariate analysis of prognostic factors in CLL: clinical stage, IGVH gene mutational status, and loss or mutation of the p53 gene are independent prognostic factorsDavid G Oscier, Anne C Gardiner, Sarah J Mould, et al.
Respiratory Research|May 21, 2022
Long-term evaluation of the safety and efficacy of recombinant human pentraxin-2 (rhPTX-2) in patients with idiopathic pulmonary fibrosis (IPF): an open-label extension studyGanesh Raghu, Mark J Hamblin, A Whitney Brown, et al.
American Journal of Respiratory and Critical Care Medicine|May 5, 2026
Deupirfenidone Compared with Pirfenidone and Placebo in Idiopathic Pulmonary Fibrosis (ELEVATE-IPF): a Phase 2b Randomized Placebo-Controlled TrialToby M Maher, Mark J Hamblin, Won-Ii Choi, et al.
British Medical Journal|November 6, 1976
Streptokinase in acute myocardial infarction: a controlled multicentre study in the United KingdomC P Aber, N M Bass, C L Berry, et al.
JAMA|May 26, 2018
Effect of Recombinant Human Pentraxin 2 vs Placebo on Change in Forced Vital Capacity in Patients With Idiopathic Pulmonary Fibrosis: A Randomized Clinical TrialGanesh Raghu, Bernt van den Blink, Mark J Hamblin, et al.
American Journal of Respiratory and Critical Care Medicine|June 30, 2022
A Phase IIb Randomized Clinical Study of an Anti-α<sub>v</sub>β<sub>6</sub> Monoclonal Antibody in Idiopathic Pulmonary FibrosisGanesh Raghu, Majd Mouded, Daniel C Chambers, et al.
Pageof 27

Showing results (251-260 of 264) with videos related to

Sort By:
Pageof 27
Journal of Immunology (Baltimore, Md. : 1950)|June 15, 1991
Nucleotide sequence analysis of the V regions of two IgM cold agglutinins. Evidence that the VH4-21 gene segment is responsible for the major cross-reactive idiotypeV Pascual, K Victor, D Lelsz, et al.
American Journal of Respiratory Cell and Molecular Biology|August 1, 1993
Cyclic mechanical deformation stimulates human lung fibroblast proliferation and autocrine growth factor activityJ E Bishop, J J Mitchell, P M Absher, et al.
Scientific Reports|February 1, 2019
The nuclear variant of bone morphogenetic protein 2 (nBMP2) is expressed in macrophages and alters calcium responseClaudia M Tellez Freitas, Haley R Burrell, Jonard C Valdoz, et al.
British Journal of Haematology|October 18, 2005
Differential expression of CD 180 and IgM by B-cell chronic lymphocytic leukaemia cells using mutated and unmutated immunoglobulin VH genesN Porakishvili, N Kulikova, A P Jewell, et al.
Blood|August 1, 2002
Multivariate analysis of prognostic factors in CLL: clinical stage, IGVH gene mutational status, and loss or mutation of the p53 gene are independent prognostic factorsDavid G Oscier, Anne C Gardiner, Sarah J Mould, et al.
Respiratory Research|May 21, 2022
Long-term evaluation of the safety and efficacy of recombinant human pentraxin-2 (rhPTX-2) in patients with idiopathic pulmonary fibrosis (IPF): an open-label extension studyGanesh Raghu, Mark J Hamblin, A Whitney Brown, et al.
American Journal of Respiratory and Critical Care Medicine|May 5, 2026
Deupirfenidone Compared with Pirfenidone and Placebo in Idiopathic Pulmonary Fibrosis (ELEVATE-IPF): a Phase 2b Randomized Placebo-Controlled TrialToby M Maher, Mark J Hamblin, Won-Ii Choi, et al.
British Medical Journal|November 6, 1976
Streptokinase in acute myocardial infarction: a controlled multicentre study in the United KingdomC P Aber, N M Bass, C L Berry, et al.
JAMA|May 26, 2018
Effect of Recombinant Human Pentraxin 2 vs Placebo on Change in Forced Vital Capacity in Patients With Idiopathic Pulmonary Fibrosis: A Randomized Clinical TrialGanesh Raghu, Bernt van den Blink, Mark J Hamblin, et al.
American Journal of Respiratory and Critical Care Medicine|June 30, 2022
A Phase IIb Randomized Clinical Study of an Anti-α<sub>v</sub>β<sub>6</sub> Monoclonal Antibody in Idiopathic Pulmonary FibrosisGanesh Raghu, Majd Mouded, Daniel C Chambers, et al.
Pageof 27